Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

We'd appreciate your feedback.Tell us what you think! opens in new tab/window

Elsevier
Publish with us
AI-Generated response:

What is the best treatment for sensory processing disorder?

Answer generated on June 4, 2024

The AI-generated responses are for illustration purposes only and should not be used for medical purposes.

The best treatment for sensory processing disorder involves a combination of occupational therapy with sensory integration therapy, educational interventions, and behavioral therapy.

Safety and efficacy of pharmacological treatments like selective 5HT3 antagonists need further investigation before they can be recommended.[1-2]

  • Occupational therapy focusing on sensory integration can help individuals manage their sensory experiences more effectively.[1]

  • Early educational interventions tailored to individual needs can help in managing sensory challenges in educational settings.[1]

  • Behavioral therapy, including techniques such as positive reinforcement and controlled sensory exposure, can aid in improving behavioral responses to sensory stimuli.[1]

  • Specific educational guidance and support can maximize potential in language, motor, and cognitive development.[1]

  • It is important to provide anticipatory guidance, educational material, and referrals to support organizations for comprehensive management.[1]

Additional info

While the use of selective 5HT3 antagonists has shown promise in improving sensory gating, their role in the treatment of sensory processing disorder specifically is not yet established, and further clinical trials are needed to understand their efficacy and safety in this context.[2] The primary approach remains non-pharmacological, focusing on therapies that address the sensory integration challenges and behavioral adaptations. It's crucial for treatments to be individualized, considering the unique sensory profiles and needs of each patient. This holistic approach helps in effectively managing the disorder and improving the quality of life for those affected.

References

Reference 1

1.

Elsevier ClinicalKey Clinical Overview

Treatment Genetic counseling Important owing to complex mode of inheritance and expression Recommend for all young adults who are affected, are known carriers, or are at risk of being carriers May result in molecular testing recommendations, discussion of risks to offspring, and discussion of options for reproductive planning Early educational intervention and individualized educational programs Programs may include small class size, individual attention, and avoidance of sudden change or excessive sensory stimulation Specific educational guidance is available to maximize potential of language, motor, and cognitive development Occupational therapy Sensory integration therapy may benefit Speech-language therapy Behavioral therapy May include measures such as positive reinforcement techniques, behavioral charting, avoidance of excessive sensory stimulation, and use of earphones with calming music Provide anticipatory guidance, educational material, and referral to support organizations National Fragile X Foundation FRAXA Research Foundation Fragile X Research Registry FORWARD (Fragile X Online Registry With Accessible Research Database) Encourage routine health care with emphasis on strategies to minimize risk of concurrent associated problems Lifestyle changes (eg, healthy diet, exercise) to address potential issues associated with increased weight Routine immunizations (eg, pneumococcal, influenza), breastfeeding for at least 4 to 6 months, and elimination of passive tobacco smoke to minimize risk of otitis media

Reference 2

2.

Tsitsipa E, Rogers J, Casalotti S, et al. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 2022;47(4):880-890. doi:10.1038/s41386-021-01255-4. Copyright License: CC BY

Publish date: March 2, 2022.

Despite these limitations, we found strong evidence that selective 5HT3 antagonists (with or without direct α7-nicotinic partial agonist effects) improved sensory gating. Future studies should investigate how this relates to potential improvement in neurocognitive symptoms in antipsychotic naive patients with prodromal or milder symptoms, in order to understand the clinical implications.

Follow up questions